City

Goshen (1)

New York (1)

Newark (1)

Orlando (1)

Philadelphia (1)

Rochester (1)

Tampa (1)

Condition

Aggressive NHL (1)

Diffuse Large B-cell Lymphoma (1)

NHL (1)

Non Hodgkin's Lymphoma (1)

Overall Status

Withdrawn (1)

Sign in for free

Phase

phase 1/phase 2 (1)

Sponsor

Gilead Sciences (1)

Collaborator

Intervention

90y-epratuzumab tetraxetan (1)

veltuzumab (1)

veltuzumab and 90y-epratuzumab tetraxetan (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

aggressive nhl

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Non Hodgkin's Lymphoma, NHL, Aggressive NHL Trial in United States (Veltuzumab and 90Y-Epratuzumab Tetraxetan, 90Y-epratuzumab

Withdrawn

Non Hodgkin's Lymphoma
+3 more

Veltuzumab and 90Y-Epratuzumab Tetraxetan
+2 more

Newark, Delaware
+6 more

Aug 12, 2021